SCHEMBL15566372

SCHEMBL15566372

Fc1ccc([C@H](F)C2CCN(c3nc4cnccc4nc3NC3CC3)CC2)c(F)c1

nearest known ligand 0.86

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR6 P46095 20/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17007707 1.00 GPR6 (0.86) GPR6
SCHEMBL17007706 1.00 GPR6 (0.86) GPR6
SCHEMBL17007718 0.93 GPR6 (1.00) GPR6
SCHEMBL17007638 0.91 GPR6 (0.85) GPR6
SCHEMBL17007674 0.91 GPR6 (0.85) GPR6
SCHEMBL17007637 0.91 GPR6 (0.85) GPR6
SCHEMBL15567253 0.90 GPR6 (0.73) GPR6
SCHEMBL15567235 0.89 GPR6 (0.73) GPR6
SCHEMBL15567234 0.89 GPR6 (0.73) GPR6
SCHEMBL15566665 0.88 GPR6 (0.86) GPR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882722-A1 QUINOXALINE DERIVATIVES AS GPR6 MODULATORS Envoy Therapeutics Inc. (US) 2015-06-17 EP disclosed
WO-2014028479-A1 QUINOXALINE DERIVATIVES AS GPR6 MODULATORS ENVOY THERAPEUTICS, INC. (US) 2014-02-20 WO disclosed